Delpharm Boucherville Canada Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 145 Rue Jules-Leger Street, Boucherville, QC J4B 7K8, Canada (CAN)
- Operations here
- analysislabelmanufacturepackrepacksterilize
- FDA identifiers
- FEI 3000280957 · DUNS 242254227
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-01-26
- NAIDrug Quality Assurance2020-02-11
- NAIDrug Quality Assurance2018-06-12
- NAIDrug Quality Assurance2016-08-09
- VAIDrug Quality Assurance2013-10-22
- OAIDrug Quality Assurance2011-08-04
- VAIDrug Quality Assurance2009-07-15
Drugs this plant is listed as making
4 distinct drugs across 6 products name this site in their FDA label.
- Norepinephrine BitartrateSandoz Inc
- Phenylephrine HydrochlorideSandoz Inc
- Pyridostigmine BromideSandoz Inc
- Rocuronium Bromidein shortageSandoz Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.